The Government has approved a 30% cap on trade margins for non-scheduled anti-cancer medicines, a move aimed at making cancer treatment more affordable. The decision is expected to ease the financial pressure on patients and their families by limiting the margins added to these medicines along the supply chain. Which Medicines Will Be Covered? The […]

Leave a comment